Table I.
Parameters for Individual Everolimus and Sorafenib Effects on Pancreatic Cancer Cells
Cell line | Drug | R 0 (%) (CV%) | IC50 (CV%) | I max (CV%) | γ (CV%) |
---|---|---|---|---|---|
MiaPaCa-2 | Everolimus | 95.67 (3.43) | 4.51 (32.16) nM | 0.39 (12.31) | 1.52 (46.31) |
Sorafenib | 88.31 (4.81) | 8.29 (6.25) μM | 1.00 (Fixed) | 3.3 (20.57) | |
Panc-1 | Everolimus | 102.5 (2.85) | 3.87 (13.83) nM | 0.41 (6.45) | 2.53 (27.23) |
Sorafenib | 100.3 (2.49) | 6.58 (5.51) μM | 1.00 (Fixed) | 2.1 (12.38) |